Caffeic acid phenethyl ester alleviated hypouricemia in hyperuricemic mice through inhibiting XOD and up-regulating OAT3
- 8 June 2022
- journal article
- research article
- Published by Elsevier in Phytomedicine
- Vol. 103, 154256
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Hyperuricemia-induced inflammasome and kidney diseasesNephrology Dialysis Transplantation, 2015
- Pegloticase immunogenicity: the relationship between efficacy and antibody development in patients treated for refractory chronic goutArthritis Research & Therapy, 2014
- Metabolic pathways newly implicated in gout epidemiologyNature Reviews Rheumatology, 2013
- Genome-wide association analyses identify 18 new loci associated with serum urate concentrationsNature Genetics, 2012
- The discovery of artemisinin (qinghaosu) and gifts from Chinese medicineNature Medicine, 2011
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011
- Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association studyThe Lancet, 2008
- SLC2A9 influences uric acid concentrations with pronounced sex-specific effectsNature Genetics, 2008
- Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemiaJournal of Neurochemistry, 2007
- Caffeic Acid Phenethyl Ester Induces Leukocyte Apoptosis, Modulates Nuclear Factor-Kappa B and Suppresses Acute InflammationNeuroimmunomodulation, 1999